Rapid test development for infectious disease states is one of the fasted growing areas of diagnostic assay development. BiosPacific is always looking for new and innovative products to bring to the market. We have expanded our portfolio to include more infectious disease markers such as Borrelia burgdorferi (Lyme), Chlamydia, CMV, Corona Virus, Dengue, HIV, Influenza A and B, Malaria HRP II, Strep A and even ZIKA. 

We also have excellent secondary antibodies for use in infectious disease serology assays. We offer IgG, IgA and IgM monoclonal antibodies as well as affinity pure polyclonals specific to different regions of the immunoglobulin proteins like Fc and H+L. 

BiosPacific can supply various antibodies and antigens for each of the disease states and we continue to develop and grow our catalog as the market grows. Please contact us to inquire about any other antibodies or proteins you may require. 

latest additions to our portfolio

• Influenza A Monoclonals• Dengue NS1 Monoclonals and Antigens• SARS-CoV-2 (COVID-19) Monoclonals and Antigens

Biospacific传染病产品传染病状态的快速检测开发是诊断检测开发快速发展的领域之一。 BiosPacific一直在寻找新的创新产品来推向市场。我们已经扩展了我们的产品组合，以包括更多的传染病标志物，例如  伯氏疏螺旋体，莱姆衣原体，CMV，冠状病毒，登革热，HIV，甲型和乙型流感，疟疾HRP II，链球菌A甚至ZIKA。 我们也有出色的二  抗  用于传染病血清学检测。我们提供  IgG，IgA和IgM  单克隆抗体，以及对免疫球蛋白蛋白质（例如Fc和H + L）不同区域具有特异性的亲和力纯多克隆。 BiosPacific可以为每种疾病提供各种抗体和抗原，并且随着市场的增长，我们将继续开发和扩大目录。请  联系我们  以咨询您可能需要的其他抗体或蛋白质。